| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in INDV over the last quarter tilts toward buying: insiders added a net 3,000 shares worth roughly $108K.
Classified under Pharmaceuticals (Health Care sector), INDV's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 790.3K | $30.29M | - | |
| CFO | 284.8K | $10.74M | - | |
| Other | 209.3K | $8.61M | - | |
| Other | 71.5K | - | - | |
| Other | 31.4K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | Anderson Woodrow D | Chief Accounting Officer | Buy | 1,500 | $35.69 | $53,535.00 | +5.7% | - | - | |
| Aug 5, 2026 | Anderson Woodrow D | Chief Accounting Officer | Buy | 1,500 | $36.28 | $54,420.00 | +6.1% | - | - | |
| Jul 10, 2026 | Heidbreder Christian | Chief Scientific Officer | Sell10b5-1 | 18,586 | $41.14 | $764,628.04 | -8.2% | -12.5% | - | |
| Jun 11, 2026 | Heidbreder Christian | Chief Scientific Officer | Sell10b5-1 | 18,586 | $38.06 | $707,383.16 | -7.5% | -8.8% | - | |
| Jun 8, 2026 | Preblick Ryan | Chief Financial Officer | Sell10b5-1 | 36,000 | $37.70 | $1,357,200.00 | -11.2% | -8.2% | - | |
| Mar 13, 2026 | Ryan Barbara | Director | Buy | 8 | $31.09 | $248.68 | +0.1% | +22.6% | - | |
| Mar 9, 2026 | Ryan Barbara | Director | Buy | 31 | $32.56 | $1,009.36 | +0.5% | +14.7% | - | |
| Mar 6, 2026 | Kingsley Stuart A | Director | Buy | 940 | $31.87 | $29,953.10 | +20.2% | +16.1% | - | |
| Jan 5, 2026 | Ryan Barbara | Director | Buy10b5-1 | 775 | $35.39 | $27,429.27 | +65.2% | -16.1% | - | |
| Jan 5, 2026 | Humphreys Keith | Director | Buy10b5-1 | 775 | $35.39 | $27,429.27 | +15.4% | -16.1% | - |